No abstract available
BACKGROUND Autologous fat grafting is commonly used for soft-tissue augmentation and reconstruction in plastic surgery. However, long-term graft retention rates are unpredictable, especially in muscle-related fat grafting. OBJECTIVE To determine whether botulinum neurotoxin type A (BoNTA) may improve supramuscular fat grafting retention by reducing muscle movement, thereby enhancing angiogenesis and adipogenesis. MATERIALS AND METHODS Pre-BTX+ nude mice were injected with BoNTA on the...
No abstract available
BACKGROUND Millennials (aged 18–34 years) represent a growing segment of the facial aesthetic market. OBJECTIVE To evaluate investigator-assessed efficacy, patient-reported outcomes (PROs), and safety for millennials versus subjects aged at least 35 years after onabotulinumtoxinA treatment of forehead lines (FHL) across 2 phase 3 studies. METHODS Eligible subjects with moderate to severe FHL received onabotulinumtoxinA (FHL: 20 U; glabellar lines: 20 U, with/without 24 U in crow's feet...
No abstract available
No abstract available
No abstract available
BACKGROUND Absorbable wedge-shaped polydioxanone (PDO) sutures are currently available for facial rejuvenation, and they are extremely popular in the aesthetic clinics in Korea. Other than face lifting, threads also can be used for nonsurgical rhinoplasty. The Asian nose is typified by a flat nasal bridge, indistinct nasal dorsum, underprojected and broad nasal tip, and a short columella. In the past, Asian rhinoplasty mainly focused on dorsal augmentation. At present, augmentation of the nasal...
No abstract available
BACKGROUND Soft-tissue filler administration is an increasingly popular minimally invasive cosmetic procedure. Simultaneously, there have been a greater number of adverse events reported, including the devastating complication of blindness. OBJECTIVE To report cases of filler-related blindness published since 2015. MATERIALS AND METHODS The Ovid MEDLINE database was searched from January 1, 2015, to August 1, 2018, using a previously described Boolean string. RESULTS Sixty new cases...
No abstract available
Mark above section as read
Publication date: Available online 25 April 2020Source: European Journal of Surgical OncologyAuthor(s): Yun-Jau Chang, Li-Ju Chen, Yao-Jen Chang, Po-Da Chen
Publication date: Available online 25 April 2020Source: European Journal of Surgical OncologyAuthor(s): Ibrahim Edhemovic, Erik Brecelj, Maja Cemazar, Nina Boc, Blaz Trotovsek, Mihajlo Djokic, Rok Dezman, Arpad Ivanecz, Stojan Potrc, Masa Bosnjak, Bostjan Markelc, Bor Kos, Damijan Miklavcic, Gorana Gasljevic, Gregor Sersa
Publication date: Available online 24 April 2020Source: European Journal of Surgical OncologyAuthor(s): W. Sanderink, M. Caballo, L. Strobbe, P. Bult, W. Vreuls, D. Venderink, I. Sechopoulos, N. Karssemeijer, R. Mann
Publication date: Available online 24 April 2020Source: European Journal of Surgical OncologyAuthor(s): Elisa Vicini, Sabrina Kahler Ribeiro Fontana, Paolo Veronesi
Publication date: Available online 24 April 2020Source: European Journal of Surgical OncologyAuthor(s): L. Vincent, C. Jankowski, L. Ouldamer, M. Ballester, S. Bendifallah, P.A. Bolze, C. Akladios, H. Costaz, V. Lavoué, G. Canlorbe, P. Collinet, C. Touboul, C. Huchon, A. Bricou, S. Dridi, M.M. Padéano, L. Bengrine, L. Arnould, C. Coutant, Groupe de Recherche FRANCOGYN
Publication date: Available online 24 April 2020Source: European Journal of Surgical OncologyAuthor(s): Zhiqin Lin, Xiaohui Zhang, Shaoshan Shen, Zhenwen Gao, Celin Guan, Tianqing Liu, Dongbin Guo, Xiaolong Qi, Xiaohui Ren, Zhongli Jiang
Publication date: Available online 23 April 2020Source: European Journal of Surgical OncologyAuthor(s): Won Ho Han, Yoon Jung Oh, Bang Wool Eom, Hong Man Yoon, Young-Woo Kim, Keun Won Ryu
Publication date: Available online 23 April 2020Source: European Journal of Surgical OncologyAuthor(s): Coco J.E.F. Walstra, Robert-Jan Schipper, Ingrid G.M. Poodt, Adriana J.G. Maaskant-Braat, Ernest J.T. Luiten, Marie-Jeanne T.F.D. Vrancken Peeters, Marjolein L. Smidt, Ellen Degreef, Adri C. Voogd, Grard A.P. Nieuwenhuijzen
Mark above section as read
Mark above section as read
Cancers, Vol. 12, Pages 1090: Integrative Transcriptome Analyses of the Human Fallopian Tube: Fimbria and Ampulla—Site of Origin of Serous Carcinoma of the Ovary Cancers doi: 10.3390/cancers12051090 Authors: Ramlogan Sowamber Omar Nelson Leah Dodds Victoria DeCastro Iru Paudel Anca Milea Michael Considine Leslie Cope Andre Pinto Matthew Schlumbrecht Brian Slomovitz Patricia A. Shaw Sophia H. L. George Epithelial ovarian cancer represents...
Cancers, Vol. 12, Pages 1088: Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression Cancers doi: 10.3390/cancers12051088 Authors: I-Han Wang Tzu-Ting Huang Ji-Lin Chen Li-Wei Chu Yueh-Hsin Ping Kai-Wen Hsu Kuo-Hung Huang Wen-Liang Fang Hsin-Chen Lee Chian-Feng Chen Chen-Chung Liao Rong-Hong Hsieh Tien-Shun Yeh The 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1) is a potential regulatory node in the mevalonate...
Cancers, Vol. 12, Pages 1089: Scientific Rationale for Combined Immunotherapy with PD-1/PD-L1 Antibodies and VEGF Inhibitors in Advanced Hepatocellular Carcinoma Cancers doi: 10.3390/cancers12051089 Authors: Masatoshi Kudo A successful phase III trial for the combination of atezolizumab and bevacizumab (the IMbrave150 trial) in advanced hepatocellular carcinoma has recently been reported. This is groundbreaking because nivolumab and pembrolizumab, both programmed cell death-1 (PD-1)...
Cancers, Vol. 12, Pages 1084: Multimodal Targeted Deep Sequencing of Circulating Tumor Cells and Matched Cell-Free DNA Provides a More Comprehensive Tool to Identify Therapeutic Targets in Metastatic Breast Cancer Patients Cancers doi: 10.3390/cancers12051084 Authors: Corinna Keup Markus Storbeck Siegfried Hauch Peter Hahn Markus Sprenger-Haussels Oliver Hoffmann Rainer Kimmig Sabine Kasimir-Bauer Cell-free DNA (cfDNA) and circulating tumor cells (CTCs)...
Cancers, Vol. 12, Pages 1086: FAK Inhibition Induces Glioblastoma Cell Senescence-Like State through p62 and p27 Cancers doi: 10.3390/cancers12051086 Authors: Lía Alza Mireia Nàger Anna Visa Carles Cantí Judit Herreros Focal adhesion kinase (FAK) is a central component of focal adhesions that regulate cancer cell proliferation and migration. Here, we studied the effects of FAK inhibition in glioblastoma (GBM), a fast growing brain tumor that has a poor prognosis....
Cancers, Vol. 12, Pages 1082: Differences of the Immune Phenotype of Breast Cancer Cells after Ex Vivo Hyperthermia by Warm-Water or Microwave Radiation in a Closed-Loop System Alone or in Combination with Radiotherapy Cancers doi: 10.3390/cancers12051082 Authors: Michael Hader Deniz Pinar Savcigil Andreas Rosin Philipp Ponfick Stephan Gekle Martin Wadepohl Sander Bekeschus Rainer Fietkau Benjamin Frey Eberhard Schlücker Udo S. Gaipl The treatment...
Cancers, Vol. 12, Pages 1085: Ribosomal Protein S27/Metallopanstimulin-1 (RPS27) in Glioma—A New Disease Biomarker? Cancers doi: 10.3390/cancers12051085 Authors: Jonas Feldheim Almuth F. Kessler Dominik Schmitt Ellaine Salvador Camelia M. Monoranu Julia J. Feldheim Ralf-Ingo Ernestus Mario Löhr Carsten Hagemann Despite its significant overexpression in several malignant neoplasms, the expression of RPS27 in the central nervous system (CNS) is widely...
Cancers, Vol. 12, Pages 1083: Crosstalk Between Prostate Cancer Cells and Tumor-Associated Fibroblasts Enhances the Malignancy by Inhibiting the Tumor Suppressor PLZF Cancers doi: 10.3390/cancers12051083 Authors: Kum Hee Noh Ae Jin Jeong Haeri Lee Song-Hee Lee Eunhee Yi Pahn-Shick Chang Cheol Kwak Sang-Kyu Ye Although prostate cancer is clinically manageable during the early stages of progression, metastatic progression severely compromises the prognosis...
Cancers, Vol. 12, Pages 1087: Application of a Biphasic Mathematical Model of Cancer Cell Drug Response for Formulating Potent and Synergistic Targeted Drug Combinations to Triple Negative Breast Cancer Cells Cancers doi: 10.3390/cancers12051087 Authors: Jinyan Shen Li Li Niall G. Howlett Paul S. Cohen Gongqin Sun Triple negative breast cancer is a collection of heterogeneous breast cancers that are immunohistochemically negative for estrogen receptor, progesterone...
Cancers, Vol. 12, Pages 1081: Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors Cancers doi: 10.3390/cancers12051081 Authors: Xiaowen Wang Matias A. Bustos Xiaoqing Zhang Romela Irene Ramos Cong Tan Yuuki Iida Shu-Ching Chang Matthew P. Salomon Kevin Tran Rebecca Gentry Yelena Kravtsova-Ivantsiv Daniel F. Kelly Gordon B. Mills Aaron Ciechanover Ying...
Cancers, Vol. 12, Pages 1080: YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance Setting Cancers doi: 10.3390/cancers12051080 Authors: Michaelis Wass Reddin Voges Rothweiler Hehlgans Cinatl Mernberger Nist Stiewe Rödel Cinatl Jr. Survivin is a drug target and its suppressant YM155 a drug candidate mainly investigated for high-risk...
Cancers, Vol. 12, Pages 1079: Erratum: Berndsen, R.H., et al. Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib, Cancers 2019, 11, 1878 Cancers doi: 10.3390/cancers12051079 Authors: Berndsen Swier van Beijnum Nowak-Sliwinska The authors wish to make the following corrections to this paper[...]
Cancers, Vol. 12, Pages 1078: Clinical Variables Associated with PSA Response to Lutetium-177-PSMA ([177Lu]-PSMA-617) Radionuclide Treatment in Men with Metastatic Castration-Resistant Prostate Cancer Cancers doi: 10.3390/cancers12051078 Authors: Moran Gadot Tima Davidson Margalit Aharon Eshetu G. Atenafu Avraham Malki Meital Levartovsky Akram Saad Liran Domachevsky Raanan Berger Raya Leibowitz Lutetium-177-PSMA ([177Lu]-PSMA-617), a radiolabeled...
Cancers, Vol. 12, Pages 1075: Overcoming Heterogeneity of Antigen Expression for Effective CAR T Cell Targeting of Cancers Cancers doi: 10.3390/cancers12051075 Authors: Sareetha Kailayangiri Bianca Altvater Malena Wiebel Silke Jamitzky Claudia Rossig Chimeric antigen receptor (CAR) gene-modified T cells (CAR T cells) can eradicate B cell malignancies via recognition of surface-expressed B lineage antigens. Antigen escape remains a major mechanism of relapse and is...
Cancers, Vol. 12, Pages 1076: Tumor-Infiltrating CD8 T Cells Predict Clinical Breast Cancer Outcomes in Young Women Cancers doi: 10.3390/cancers12051076 Authors: Yong Won Jin Pingzhao Hu Young women with breast cancer have disproportionately poor clinical outcomes compared to their older counterparts. The underlying biological differences behind this age-dependent disparity are still unknown and warrant investigation. Recently, the tumor immune landscape has received much attention...
Cancers, Vol. 12, Pages 1074: Imaging Accuracy in Preoperative Staging of T3-T4 Laryngeal Cancers Cancers doi: 10.3390/cancers12051074 Authors: Marco Benazzo Fabio Sovardi Lorenzo Preda Simone Mauramati Sergio Carnevale Giulia Bertino Francesca Berton Matteo Meroni Irene Herman Giuseppe Trisolini Patrizia Morbini Background: Preoperative imaging impacts treatment planning and prognosis in laryngeal cancers. We investigated the accuracy of...
Cancers, Vol. 12, Pages 1073: LINC00963 Promotes Cancer Stemness, Metastasis, and Drug Resistance in Head and Neck Carcinomas via ABCB5 Regulation Cancers doi: 10.3390/cancers12051073 Authors: Shiao-Pieng Lee Pei-Ling Hsieh Chih-Yuan Fang Pei-Ming Chu Yi-Wen Liao Chuan-Hang Yu Cheng-Chia Yu Lo-Lin Tsai Accumulating studies have indicated that long non-coding RNAs (lncRNAs) participate in the regulation of cancer stem cells (CSCs), which are crucial in...
Cancers, Vol. 12, Pages 1077: Cognitive Functions in Repeated Glioma Surgery Cancers doi: 10.3390/cancers12051077 Authors: Capo Skrap Guarracino Isola Battistella Ius Tomasino Low-grade gliomas (LGG) are slow-growing brain tumors infiltrating the central nervous system which tend to recur, often with malignant degeneration after primary treatment. Re-operations are not always recommended due to an assumed higher risk of neurological and cognitive deficits....
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου